课题基金 / 基金详情

Assessment of antigen processing and presentation of CD40 activated B cells

Assessment of antigen processing and presentation of CD40 activated B cells
CD40 活化 B 细胞的抗原加工和呈递评估
批准号:
21890147
负责人:
KONDO Eisei
金额:
$1.66万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Research Activity Start-up
财政年份:
2009
资助国家:
日本
项目状态:
已结题
起止时间:
2009 至 2010

项目摘要

项目成果

KONDO Eisei的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
It has been demonstrated that CD40-activated B (CD40-B) cells are potent antigen presenting cells that can be expanded significantly ex vivo.Several methods to antigen load CD40-Bs to generate viral or tumor-antigen specific CD8+ T cells have been identified. However, it is unclear how CD40-Bs take up and process exogenous antigen in an B cell receptor independent manner to stimulate CD4+ T cells. CD4+ T cells specific for multiple epitopes were successfully generated in stimulation with CD40-B cells pulsed with recombinant protein. In addition, CD40-Bs were able to be easily transfected with in vitro transcribed-mRNA. CD40-B cells are thought to be useful in cellular therapy.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
Cyclin D1 as a widely expressed tumor antigen : generation of high avidity CTL in an autologous setting
细胞周期蛋白 D1 作为广泛表达的肿瘤抗原:在自体环境中生成高亲和力 CTL
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [Kiba W, Imazato S, Takahashi Y, Yoshioka S, Ebisu S, Nakano T., 近藤英生]
通讯作者: 近藤英生
Identification of native, immunogenic peptides from Cyclin D1.
从 Cyclin D1 中鉴定天然免疫原性肽。
DOI: --
发表时间: 2010
期刊: Leukemia 24
影响因子: --
作者: [von Bergwelt-Baildon MS, Shimabukuro-Vornhagen A, Wendtner CM, Kondo E]
通讯作者: Kondo E
Cyclin A2特異的High-avidity CTLの樹立
Cyclin A2特异性高亲和力CTL的建立
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [Klein-Gonzalez N, Kondo E, von Bergwelt-Baildon MS., Kobashi H, 近藤英生]
通讯作者: 近藤英生
Cyclins against cancer : a novel family of tumor antigens?
抗癌细胞周期蛋白:一个新的肿瘤抗原家族?
DOI: --
发表时间: 2010
期刊: Immunotherapy. 2
影响因子: --
作者: [Klein-Gonzalez N, Kondo E, von Bergwelt-Baildon MS.]
通讯作者: von Bergwelt-Baildon MS.
Development of monitoring systems for CMVpp65 specific CTLs restricted to each HLA class I.
  • 批准号:
    23591418
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.41万
  • 财政年份:
    2011
  • 负责人:
    KONDO Eisei
  • 依托单位: